<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="diphosphate (CQ; C6628) was purchased from Sigma‐Aldrich (St. Louis, MO)," exact="lopinavir" post="(LPV; S1380) was purchased from SelleckChem (Houston, TX), and"/>
 <result pre="Saline (DPBS; Welgene), and all other reagents were dissolved in" exact="dimethyl sulfoxide" post="(DMSO) for the screening. Anti‐SARS‐CoV‐2 N protein antibody was"/>
 <result pre="Vero and Calu‐3 cells. While the IC50 values of both" exact="chloroquine" post="and lopinavir increased by approcimately 10 folds and 2"/>
 <result pre="Calu‐3 cells. While the IC50 values of both chloroquine and" exact="lopinavir" post="increased by approcimately 10 folds and 2 folds, respectively"/>
 <result pre="IC50 (Figure 2B) (Table 2): nafamostat mesylate, camostat mesylate, remdesivir," exact="hydroxyprogesterone" post="caproate, digitoxin, and cyclosporine. Although nafamostat mesylate and camostat"/>
 <result pre="Microbiol. 2020;5(4):536‐544. 10.1038/s41564-020-0695-z32123347 3WangM, CaoR, ZhangL, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019‐nCoV) in"/>
 <result pre="bioRxiv. 202010.1101/2020.04.27.064279 7GelerisJ, SunY, PlattJ, et al. Observational study of" exact="hydroxychloroquine" post="in hospitalized patients with COVID‐19. N Engl J Med."/>
 <result pre="SampaioVS, et al. Effect of high vs low doses of" exact="chloroquine" post="diphosphate as adjunctive therapy for patients hospitalized with severe"/>
</results>
